Tuesday, Jul 23 2024 | Time 01:07 Hrs(IST)
image
Business Economy


HMD develops safety needle syringes to protect health workers against needle-stick injuries

Hyderabad, Mar 21 (UNI) Hindustan Syringes and Medical Devices (HMD), one of the leading manufacturers of disposable and auto-disable syringes in the world, announced on Thursday that it has launched the most innovative and first-of-its-kind Dispojekt single-use syringes with safety needles in Hyderabad.
The launch aligns with India's efforts to become a self-reliant hub for medical device manufacturing and exporting.,. company said. in a release here.
With the revolutionary Dispojekt safety syringes, HMD aims to reduce the prevalence of accidental Needle Stick Injuries (NSIs) among health workers, reduce infection control costs, and reduce disposal and training costs, offering a long-term positive financial impact on the healthcare sector.
“Equipped with a safety shield (SIP shield), the Dispojekt syringe addresses critical concerns of needle stick injuries and reaffirms our commitment as market leaders towards excellence in healthcare. It is a great outcome of our Make in India resolve as envisioned by Prime Minister Narendra Modi to realise the goal of Viksit Bharat,” said Rajiv Nath, Managing Director, HMD.
He said that India is poised to become a global powerhouse in the manufacturing and exporting of medical devices, in sync with the spirit of Atma Nirbhar Bharat.
The disposable syringe market size in India is estimated to be over 5 billion units per year and 5–6 billion needles, 80% of which are in the hands of private sector players.
“We aim for 60–70 per cent market share in the next three years, thanks to our innovative Dispojekt,” said Executive Director Sohail Nath.
“Dispojekt safety needle syringes are going to be the game changer in the global fight against NSIs. We are aiming to initially produce 200 million syringes and needles per year, for which we have invested approximately Rs 70 crore in the first phase,” said Sohail.
“In the second phase, we will increase the capacity to 300 million pieces per year by investing another Rs 10 crore to Rs 15 crore,” he said.
As one of the most reputed medical device manufacturers with multiple state-of-the-art manufacturing facilities in Faridabad, Haryana, HMD produces over 4 billion injection needles per year, catering to the needs of its primary markets, comprising India, Europe, the US, the Middle East, and its secondary markets of Southeast Asia and Africa.
Dispojekt safety needle syringes will not only further strengthen our position as market leaders but will also boost the global collective efforts of the WHO to check NSIs leading to the transmission of bloodborne diseases like Hepatitis B, C, and HIV among healthcare personnel, betting on their quality, uniqueness, and affordability, he said.
“Dispojekt safety needle syringes have been designed to be affordable for the developing world, including India, and are nearly half the cost of safety single-use syringes used in the USA and Europe, where 100 per cent usage is mandatory by legislation,” he added.
According to research, the prevalence of NSIs among healthcare workers in India is between 57% and 73%.
Approximately 54% of NSIs are reported because of the use of hypodermic needles. Many instances of NSIs go unreported, making it a way more serious problem than it appears, the release said.
The Centre for Disease Control and Prevention, US, has estimated that only 10% of NSI injuries are reported. In developing countries, which have the highest global prevalence of HIV, the prevalence of needle stick injuries is also at its highest level. Studies report an annual rate of 100,000 injuries caused by sharp objects among nurses in the UK as well.
The launch of Dispojekt safety needle syringes, an innovative and cost-effective product from the R&D lab of the world’s largest manufacturer of auto-disable (AD) syringes, assumes significance in view of the monstrous magnitude of NSIs among health workers,the release added.
UNI KNR AKS
More News
Sensex drops 102 57 points on eve of budget

Sensex drops 102 57 points on eve of budget

22 Jul 2024 | 6:44 PM

Mumbai, July 22 (UNI) India’s benchmark indices continued losing streak for the second day as the BSE Sensex lost 102.57 points to settle at 80,502.88 mainly due to weak global cues and as a caution on the eve of general budget by the Modi government on Tuesday.

see more..

Sensex drops 102 57 points on eve of budget

22 Jul 2024 | 6:36 PM

Mumbai, July 22 (UNI) India’s benchmark indices continued losing streak for the second day as the BSE Sensex lost 102.57 points to settle at 80,502.88 mainly due to weak global cues and as a caution on the eve of general budget by the Modi government tomorrow.

see more..
Time to look at next set of reforms for higher eco growth: FICCI

Time to look at next set of reforms for higher eco growth: FICCI

22 Jul 2024 | 6:22 PM

New Delhi, July 22 (UNI) The Indian industry said on Monday that it is time to look at the next leap on the reform trajectory that would prepare India for achieving higher growth.

see more..

22 Jul 2024 | 6:20 PM

Chennai, July 22 (UNI) The Indian Overseas Bank (IOB) on Monday reported a significant increase
in its financial performance for the quarter, with the net profit rising by 26.60% to Rs 633 crores, compared to Rs 500 crores in the same period last year.

see more..

IDBI net up 40 pc in Q1

22 Jul 2024 | 6:17 PM

New Delhi, July 22 (UNI) IDBI bank on Monday reported a 40 percent jump in net profit at Rs 1,719 crore in the Q1 (April-June) of 2024-25 as against Rs 1,224 crore in Q1 of fiscal 2023-24.

see more..
image